Kristiina Ojamaa

Ravi St 18
Tallinn, 10138, Estonia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Exploring the somatic mutational landscape of ovarian cancer in Estonia.

Exploring the somatic mutational landscape of ovarian cancer in Estonia.

Journal: Acta oncologica (Stockholm, Sweden)

Published: February 24, 2026

Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Procedures of data merging in precision cancer medicine: the PRIME-ROSE project.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 17, 2025

A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium.

A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortium.

Journal: ESMO open

Published: July 29, 2025

Clinical Implementation Study of Genetic Risk-Based Breast Cancer Screening.

Clinical Implementation Study of Genetic Risk-Based Breast Cancer Screening.

Journal: Clinical breast cancer

Published: February 28, 2025

Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores.

Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores.

Journal: Cancers

Published: February 21, 2025

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 22, 2023

A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases.

A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 29, 2021

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 28, 2019

Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades.

Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades.

Journal: Cancer epidemiology

Published: May 08, 2019

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia.

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia.

Journal: BMC cancer

Published: February 28, 2019

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.

Journal: BMC cancer

Published: May 24, 2018

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 22, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026